1)docetaxel多西他赛
1.Preparation and characteristics of docetaxel nanos-tructure lipid carriers;多西他赛纳米脂质载体的制备及其性质考察
2.Determination of Docetaxel and Its Injection by HPLC;HPLC法测定多西他赛及注射液的含量
3.Complexation of docetaxel with β-cyclodextrin and HP-β-cyclodextrin;多西他赛与β-环糊精及羟丙基-β-环糊精包合作用的研究
英文短句/例句
1.Antiangiogenic experiment of docetaxel chemotherapy in lung cancer-bearing murine model多西他赛抑制小鼠肺癌血管生成分析
2.Experimental Study on Treatment of Human Gastric Cancer Cell Line SGC7901 with Combination of TRAIL and Paclitaxe;多西他赛联合TRAIL诱导胃癌细胞凋亡的机制探讨
3.Biological parameters treated with neoadjuvant docetaxel chemotherapy多西他赛治疗Ⅱ/Ⅲ期乳腺癌生物学指标研究
4.Regimen based on platinum compound plus docetaxel for the treatment of advanced esophageal carcinoma as a first-line drug铂类联合多西他赛一线治疗晚期食管癌
5.Effects of Sub-dose Administration on Prevention of Docetaxel-induced Allergic Reactions分次给药法预防多西他赛过敏反应的效果观察
6.Content determination of docetaxel in rat plasma by protein precipitation and HPLC method蛋白沉淀-HPLC法测定大鼠血浆中多西他赛的含量
7.Clinical study of docetaxel for advanced non-small cell lung cancer多西他赛治疗晚期非小细胞肺癌的临床观察
8.Determination of Residual Solvents in Docetaxel by Capillary GC毛细管气相色谱法测定多西他赛中的残留溶剂
9.Combination of docetaxel and capecitabine in the neoadjuvant chemotherapy of breast cancer多西他赛联合卡培他滨在乳腺癌新辅助化疗中的应用
10.Docetaxel in Combination with Xeloda in the Treatment of Elderly Patients with Advanced Gastric Cancer多西他赛联合卡培他滨治疗老年晚期胃癌的疗效分析
11.Combination Chemotherapy with Docetaxel,Capecitabine and Oxaliplatin in the Treatment for 45 Cases with Advanced Gastric Cancer多西他赛联合卡培他滨和奥沙利铂治疗晚期胃癌45例
12.Investigation of Preparation and Pharmacokinetics for Freeze-dried Docetaxel Liposome;多西他赛脂质体冻干制剂的制备与药代动力学研究
13.Antitumor Activity of C225 in Combination with Docetaxel in Human Gastric Carcinima Cell Lines MGC803 and BGC823 in Vitro;C225联合多西他赛在人胃癌细胞株MGC803及BGC823中的体外研究
14.The Antineoplastic Activity of the Docetaxel in Human Breast Cancer Cell Line MCF-7 Pretreated by Dexamethasone;地塞米松预处理人乳腺癌MCF-7细胞对多西他赛抗肿瘤活性的影响
15.The Study on Effects of Rh-endostatin and Docetaxel on HUVECs恩度对血管内皮细胞的影响及其与多西他赛联合作用的观察
16.Synthesis of N-acyl chitosan derivatives and investigation of chitosan-modified docetaxel liposomes in vitroN-酰化壳聚糖的合成及其修饰多西他赛脂质体的体外性质研究
17.Preparation of Docetaxel Hydrogels for Subcutaneous Injection and Their Release Profile in Vitro多西他赛皮下注射缓释凝胶的制备及其体外释放行为研究
18.Clinical Study of Docetaxel Combined with Cisplatin and 5-Fu in the Treatment of Patients with Metastatic Esophageal Cancer多西他赛联合顺铂和5-氟脲嘧啶治疗转移性食管癌的临床研究
相关短句/例句
taxotere多西他赛
1.Three-weeks’ and weekly taxotere/cisplation treatment in non-small-cell lung cancer;多西他赛联合顺铂三周方案与每周方案治疗非小细胞肺癌
2.Concurrent Weekly Taxotere and Three-dimensional Conformal Radiation Therapy for Elderly Patients with Advanced Non-smallCell Lung Cancer多西他赛同步三维适形放疗治疗老年晚期非小细胞肺癌效果观察
3.Objective:To assess the efficacy and toxicity of taxotere/cisplatin (TP) and vinorelbine/cisplatin in patients with advanced non-small cell lung cancer (NSCLC).方法74例进展期非小细胞肺癌,分为TP方案组应用多西他赛加顺铂静脉滴注,NP方案组应用长春瑞滨加顺铂静脉滴注,同时给予水化、利尿等处理,21天为1个周期,4个周期后评价疗效。
3)Docetaxe多西他赛
1.Curative Effects of Docetaxe or Oxaliplatin Combined with Xeloda in Advanced Gastric Cancer多西他赛或奥沙利铂联合希罗达治疗晚期胃癌的疗效对比
2.Docetaxel combined with Epirubicin and Cytoxan and 5-FU for locally advanced breast cancer neoadjuvant chemotherap多西他赛联合表柔比星、环磷酰胺和氟尿嘧啶治疗局部晚期乳腺癌
3.Conclusion:Docetaxel combind with xeloda is active for the patients with anthracycline-resistant metastatic breast canccr,and toxic side effects is acceptably tolerant.目的:观察希罗达联合多西他赛治疗蒽环类失败复发转移性乳腺癌的临床疗效和毒副反应。
4)Dopafei(Docetaxel)多帕菲(多西他赛)
5)Docetaxel for injection注射用多西他赛
1.Determination of the content and related substances in Docetaxel for injection by HPLC;HPLC测定注射用多西他赛的含量并检查有关物质
6)Synthesis of Docetaxel多西他赛的合成
延伸阅读
多西他赛分子式:C43H55NO13分子量:793.99CAS号:114977-28-5性质:暂无制备方法:暂无用途:抗肿瘤植物药,用于转移性乳腺癌和非小细胞肺癌。